Rongfeng Fu
Overview
Explore the profile of Rongfeng Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang P, You N, Ding Y, Zhu W, Wang N, Xie Y, et al.
Nat Commun
. 2024 Apr;
15(1):2989.
PMID: 38582902
Despite the identification of driver mutations leading to the initiation of myeloproliferative neoplasms (MPNs), the molecular pathogenesis of MPNs remains incompletely understood. Here, we demonstrate that growth arrest and DNA...
12.
Sun T, Chen J, Xu Y, Li Y, Liu X, Li H, et al.
Br J Haematol
. 2024 Mar;
204(6):2418-2428.
PMID: 38513635
This study aimed to identify key proteomic analytes correlated with response to splenectomy in primary immune thrombocytopenia (ITP). Thirty-four patients were retrospectively collected in the training cohort and 26 were...
13.
Li Y, Chen J, Sun T, Chen Y, Fu R, Liu X, et al.
Blood Cancer J
. 2024 Mar;
14(1):48.
PMID: 38499533
No abstract available.
14.
Li Y, Sun T, Chen J, Liu X, Fu R, Xue F, et al.
Br J Haematol
. 2024 Mar;
204(6):2405-2417.
PMID: 38438130
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by antibody-mediated platelet destruction and impaired platelet production. The mechanisms underlying ITP and biomarkers predicting the response of drug treatments are elusive....
15.
Yu D, Xue F, Liu X, Chen Y, Fu R, Sun T, et al.
Res Pract Thromb Haemost
. 2024 Mar;
8(1):102318.
PMID: 38433975
Background: Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by factor (F)VIII inhibitors. The diagnosis and management of AHA remains challenging because of its rarity and heterogeneity. Objectives:...
16.
Zhang W, Xie S, Fu R, Chen Y, Liu W, Sun T, et al.
Expert Rev Hematol
. 2023 Nov;
16(12):1125-1133.
PMID: 38009277
Background: There is lacking studies of longitudinally assessment of fatigue and health-related quality of life (HRQoL) among Chinese immune thrombocytopenia (ITP) adults. We aimed to evaluate changes in fatigue and...
17.
Chen Y, Xu Y, Huang Y, Sun T, Hu Y, Xue F, et al.
Am J Hematol
. 2023 Oct;
99(1):E22-E25.
PMID: 37883528
No abstract available.
18.
Wang P, Zhou R, Xue F, Zhou H, Bai J, Wang X, et al.
Am J Hematol
. 2023 Oct;
99(1):28-37.
PMID: 37851608
Acquired hemophilia A (AHA) is a rare but serious bleeding disorder. Randomized controlled trial (RCT) comparing the efficacy of immunosuppression therapy for AHA lacks. We conducted the first multicenter RCT...
19.
Gao Y, Chi Y, Chen Y, Wang W, Li H, Zheng W, et al.
Nat Commun
. 2023 Jul;
14(1):4373.
PMID: 37474525
Mesenchymal stem cells (MSCs) possess potent immunomodulatory activity and have been extensively investigated for their therapeutic potential in treating inflammatory disorders. However, the mechanisms underlying the immunosuppressive function of MSCs...
20.
Fu R, Dong H, Zhang D, Zhou H, Zhang X, Huang Y, et al.
Ann Hematol
. 2023 Jun;
102(8):2097-2107.
PMID: 37354213
Approximately half of patients diagnosed with essential thrombocythemia (ET) are older adults (aged ≥ 60 years), but to date, little is known about the clinical and molecular characteristics of older...